Pentagon taps Zoll Medical for $400M contract to provide vital signs monitors

Pentagon

Zoll Medical, a devicemaker based in Chelmsford, MA, has received a $400 million contract from the Pentagon to provide the U.S. Army and Air Force with monitors that will be used to check vital signs.

The $400 million is the maximum amount for the deal that has a one-year base contract with 5 one-year option periods. The contract was a competitive acquisition with three responses received, the Pentagon said in a press release.

Few additional details were provided in the release by the military.

Zoll develops and markets medical devices and software for emergency care services. The company's products include defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation. Its primary customers include EMS and fire professionals, and lay rescuers who are typically first responders for victims needing resuscitation and acute critical care.

The company is a wholly owned subsidiary of Asahi Kasei of Japan, which bought Zoll in 2012 for about $2.21 billion.

Zoll was founded by Dr. Paul Zoll, who was the first physician to show that external electrical stimulation of a patient's chest during cardiac arrest could produce an effective heartbeat, and was the first doctor to successfully use external defibrillation to regulate heart rhythms in patients.

- check out the Pentagon's release

Suggested Articles

CRISRP Therapeutics will likely be hit by the pandemic.

Pandion will test its lead program in patients with refractory ulcerative colitis and move a second program into phase 1.

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.